Growth Metrics

Orthopediatrics (KIDS) Gains from Investment Securities (2020 - 2026)

Orthopediatrics has reported Gains from Investment Securities over the past 7 years, most recently at $793000.0 for Q1 2026.

  • For Q1 2026, Gains from Investment Securities fell 52.85% year-over-year to $793000.0; the TTM value through Mar 2026 reached -$889000.0, up 52.84%, while the annual FY2023 figure was -$3.0 million, 88.51% up from the prior year.
  • Gains from Investment Securities for Q1 2026 was $793000.0 at Orthopediatrics, up from -$4.8 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $2.6 million in Q1 2022 and troughed at -$23.0 million in Q3 2022.
  • A 5-year average of -$2.1 million and a median of -$347000.0 in 2024 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 53566.67% in 2024 and later skyrocketed 569.45% in 2025.
  • Year by year, Gains from Investment Securities stood at -$480000.0 in 2022, then surged by 98.75% to -$6000.0 in 2023, then tumbled by 53566.67% to -$3.2 million in 2024, then tumbled by 49.44% to -$4.8 million in 2025, then skyrocketed by 116.48% to $793000.0 in 2026.
  • Business Quant data shows Gains from Investment Securities for KIDS at $793000.0 in Q1 2026, -$4.8 million in Q4 2025, and $1.5 million in Q3 2025.